3 e et d

w90toiiCabe

HAMRS

h

R

PmWCa

b

c

d

e

f

g

h

IppMtiffvr(tRyoipimoRuiRm

Cwtl

h

LpsH

BsdaarMjamRtafiwrbvwpCdcss

h

H

MfP

I3etOshr«Mafpc

98 Abstracts / Annales de Cardiologi

ere all more frequent in C patients. Coronary angiography was performed in9.6% of P vs 93% of C patients; PCI was used in 94% vs 72%, and CABG in.8% and 3.8%, respectively. Using several types of propensity score matchingo adjust for differences in baseline characteristics of patients treated with Pr C, use of prasugrel was associated with a non-significant trend to decreasedn-hospital mortality, and there was no increase in bleeding and no decrease inschemic events.onclusion.– Patients receiving prasugrel more often presented with STEMInd were at a lower risk than those receiving clopidogrel. After adjustment foraseline differences, no difference was noted in the risk of bleeding or ischemicvents.

Clopidogrelonly(n = 2856)

Prasugrelonly(n = 391)

Any Prasugrel(n = 1259)

Adjusted OR(P only vs Conly)

ospital death 3.6% 0.5% 0.4% 0.41 (0.05–3.30)ny bleeding 8.0% 7.4% 6.4% 1.16 (0.72–1.87)ajor bleeding 1.2% 1.0% 0.4% 1.34 (0.36–4.97)ecurrent MI 0.9% 0.8% 1.4% 2.23 (0.60–8.37)troke 0.3% 0.3% 0.5% 3.32 (0.21–55.6)

ttp://dx.doi.org/10.1016/j.ancard.2012.08.012

ythmologie

acemaker patients’ perception of daily life activities andedical follow-up: A French survey. Amara a, S. Cheggour b, J. Taieb c, H. Salih a, I. Benyoussef a, P. Sagnol d,. Gully e, N. Rabah f, A. Milhem g, A. Bonny h, P. Bru g

Cardiology, GHI le Raincy-Montfermeil, Monfermeil, FranceCardiology, hôpital Henri-Duffaut, Avignon, FranceCardiology, CH du Pays d’Aix, Aix en Provence, FranceCardiology, CH William-Morey, Châlon sur Saone, FranceCardiology, CHD Les Oudairies, La Roche sur Yon, FranceCardiology, CHI Eure-Seine, Evreux, FranceCardiology, CH St-Louis, La Rochelle, FranceCardiology, hôpital Ste-Camille, Bry sur Marne, France

ntroduction.– Patients may have misconceptions about pacemakers arising fromopular notions or outdated information. The aim of our study was to assessatients’ knowledge about pacemakers after the implantation.aterial and methods.– We performed a multicenter survey in 8 French cen-

ers from January to December 2011. In each center, patients received usualnformations (delivered by nurses and doctors) about pacemaker implantation,unctioning, and about their habits after the implantation. They signed a consentorm for implantation. One to 7 days after implantation, each patient recei-ed a questionnaire to evaluate his perceptions about information and consent,isks of implantation, follow up, and ability to perform various routine activitiesdaily life activities, use of electrical devices), and to undergo medical imagingests.esults.– We included 160 patients. The mean age was 75.2 + 10.6 years (40–93rs) and 59% were men. The intervention was a primary implantation in 86.7%f patients. Seventy-six percent of patients remembered that they have receivednformations and 81% that they have signed a consent form in the perioperativeeriod. A large number of patients considered many routine activities unsafencluding driving automobiles (15.5%), swimming (14.7%), passing through

etal detectors (48%), sleeping on the side of the pacemaker (12%). Indeed, 28%f patients think they can use induction hobs and 16% arc welding equipment.egarding medical imaging, 9%, 4% and 6.5% of patients considered unsafe tondergo scanners, radiography and echography respectively, and 36% ignored

f they can have MRI.egarding medical follow up, 10.6% of patients think they don’t need heartedications and 16% that they are exempt from monitoring by a cardiologist.

Psà

’Angéiologie 61 (2012) 394–401

onclusion.– The results of our study highlight patients’ misperceptions on lifeith a pacemaker. This should lead cardiologists to better inform patients at the

ime of pacemaker implantation, allowing improvement in patient’s quality ofife.

ttp://dx.doi.org/10.1016/j.ancard.2012.08.013

ong-term follow-up after implantable loop recorder inatients with syncope: Results of a French general hospitalurvey. Salih , F. Monsel , J. Sergent , W. Amara

Cardiologie, GHI Le Raincy-Montfermeil, Montfermeil, France

ackground and objective.– Despite recent advances in diagnostic procedures,yncope remains unexplained in 15 to 35% of patients. If implantable loop recor-er is a validated diagnostic tool for unexplained syncope, results of this strategyre largely issued from randomized studies. We lack the results of surveys. Theim of this study was to report a single center experience with implantable loopecorder, in patients with unexplained syncope.

ethods.– A device (Medtronic Reveal) was implanted in 30 patients betweenanuary 2009 and january 2012. During a mean follow-up of 10.5 ± 8.5 monthsfter device implantation, loop recording definitively determined that an arrhyth-ia was the cause of symptoms in nine patients (30%).esults.– Thirteen patients (41%) experienced syncope or pre-syncope. In six of

he 13 patients with syncope during follow-up no diagnosis could be made (nonrrhythmic causes; one patient has been diagnosed as presenting epilepsy andve as having hypotensive vasovagal syncope). In seven patients, the ILR sho-ed an arrhythmic aetiology. Two other patients presented an abnormal ILR

esults without symptoms. Diagnosis included sinusal arrest in three patients,radycardia in one patient, advanced atrio-ventricular block in three patients andentricular arrythmias in two patients. Therapy was instituted in all patients, inhom an arrhythmic cause was found except one who refused the therapy (sixacemaker and two implantable cardioverter defibrillator implantations).onclusion.– In this registry, implantable loop recorder implantation led to theiagnosis of an arrhythmic cause in 30% of patients and excluded an arrhythmicause in 15% of patient with a mean follow-up of 10.5 months. This percentageeems to be lower than those reported in randomized studies. These resultshould be confirmed in a larger multicentric survey.

ttp://dx.doi.org/10.1016/j.ancard.2012.08.014

ypertension artérielle

anagement de l’hypertension en télémédecine : étude deaisabilité et résultats sur 100 patients. Dary

Cabinet de cardiologie, St-Yrieix, France

ntroduction.– L’étude nationale nutrition santé menée en 2006–2007 estime à1 % la prévalence de l’hypertension dans la population des 18 à 74 ans. Parmiux, 20 % des personnes avec une HTA ne sont pas pris en charge. Parmi cellesraitées, 49,1 % ont une tension non contrôlée.bjectifs.– Cette étude observationnelle a pour objectif d’évaluer la faisabilité du

uivi en télémédecine de la pression artérielle sur une population de 100 patientsypertendus, connaître le profil tensionnel et adapter le traitement en tempséel afin d’en améliorer le contrôle. Ce travail est lauréat de la compétition1 mission, 1 million », prévenir l’AVC.éthode.– La télésurveillance des chiffres tensionnels se fait par automesure

vec six prises quotidiennes chez des hypertendus non stabilisés. Le suivi seait en trois phases : inclusion, observation, traitement. La tension est mesuréear méthode oscillométrique, les résultats sont transmis par module GSM etonsultables sur un serveur sécurisé.

rofil des patients.– L’âge moyen est de 68 ans, 44 hommes et 56 femmes, 18 %ont pris en charge pour de l’arythmie, 19 % n’ont aucun traitement. La tensionl’inclusion est de 175/92.